ventilation

The Role of Mechanical Ventilation in ARF Management

by ICU Ventilator

Mechanical ventilation plays a critical role in addressing the pathophysiological mechanisms underlying acute respiratory failure (ARF). By correcting gas exchange abnormalities, reducing respiratory muscle workload, and preventing complications, it provides essential support for patients in critical conditions (1,5,7,8). Below, specific mechanisms of mechanical ventilation are linked to the pathophysiological issues they target to enhance clarity and coherence.

Correction of Hypoxemia

One of the primary goals of mechanical ventilation in ARF is to address hypoxemia caused by mechanisms such as ventilation-perfusion (V/Q) mismatch, shunting, or diffusion impairment.

  • Mechanism: Mechanical ventilation increases the fraction of inspired oxygen (FiO₂), ensuring higher oxygen availability in the alveoli, which is crucial for patients with reduced oxygenation due to pneumonia, ARDS, or pulmonary embolism.
  • PEEP (Positive End-Expiratory Pressure): PEEP prevents alveolar collapse during exhalation by maintaining positive pressure in the lungs, thereby improving functional residual capacity (FRC). This is particularly effective in conditions involving alveolar instability, such as ARDS or atelectasis.
  • Link to Pathophysiology: In cases of shunting, where blood bypasses ventilated alveoli, PEEP recruits collapsed alveoli and redistributes ventilation, reducing hypoxemia.

Removal of Hypercapnia

Hypercapnia in ARF arises from hypoventilation or increased dead space, as seen in conditions like COPD exacerbations or severe obesity hypoventilation syndrome.

  • Mechanism: Mechanical ventilation increases minute ventilation by optimizing tidal volume (VT) and respiratory rate. By enhancing the removal of carbon dioxide, it normalizes arterial pH and relieves respiratory acidosis.
  • Pressure-Control Ventilation (PCV): PCV is particularly beneficial in hypercapnic ARF as it delivers preset pressure during inspiration, ensuring adequate ventilation while minimizing airway pressures.
  • Link to Pathophysiology: In hypoventilation-related hypercapnia, increasing ventilatory support reduces carbon dioxide retention, reversing acidemia and preventing hemodynamic instability.

Reduction of Work of Breathing

ARF often places a high workload on respiratory muscles, leading to fatigue and eventual failure, especially in conditions like COPD exacerbations or severe asthma.

  • Mechanism: Mechanical ventilation reduces the effort required to breathe by delivering positive pressure during inspiration. Modes like pressure support ventilation (PSV) and assist-control ventilation (ACV) enable respiratory muscle rest while maintaining adequate ventilation.
  • Link to Pathophysiology: By decreasing the work of breathing, mechanical ventilation prevents respiratory muscle exhaustion, a key contributor to hypercapnic ARF.

Alveolar Recruitment and Stabilization

Alveolar recruitment strategies are critical for restoring effective gas exchange in conditions like ARDS, where alveolar collapse and severe V/Q mismatch are common.

  • Mechanism: PEEP and lung-protective ventilation strategies, such as low tidal volumes, recruit and stabilize alveoli, increasing the surface area available for gas exchange.
  • Link to Pathophysiology: In ARDS, where alveolar collapse exacerbates shunting, PEEP opens collapsed alveoli, improving oxygenation and reducing the severity of hypoxemia.

Prevention of Secondary Complications

Mechanical ventilation provides controlled respiratory support that reduces the risk of secondary complications such as aspiration, ventilator-associated pneumonia (VAP), or multi-organ failure.

  • Mechanism: Secure airway management with invasive mechanical ventilation protects against aspiration, while precise ventilator settings minimize barotrauma and ventilator-induced lung injury (VILI).
  • Link to Pathophysiology: By addressing hypoxemia and hypercapnia, mechanical ventilation prevents systemic complications like hypoxia-induced multi-organ failure and maintains hemodynamic stability.

Mechanical ventilation compensates for the physiological disruptions seen in ARF by targeting specific mechanisms like V/Q mismatch, diffusion impairment, and increased work of breathing. Each intervention, whether optimizing oxygenation, reducing carbon dioxide levels, or stabilizing alveolar function, is tailored to the patient’s underlying pathology.

This ensures effective management of ARF while minimizing complications, emphasizing the indispensable role of mechanical ventilation in critical care settings (1-8,10).

Types of Mechanical Ventilation

Mechanical ventilation is classified into invasive and non-invasive methods, each with specific applications based on the patient’s condition and therapeutic needs (9-11). Both types play a vital role in the management of acute respiratory failure (ARF), with the choice determined by the severity of respiratory dysfunction and the clinical response to treatment (10).

Non-Invasive Ventilation (NIV)

Non-invasive ventilation delivers respiratory support through a mask or nasal interface, avoiding the need for intubation. It is particularly effective in patients with mild to moderate ARF who are conscious and able to protect their airway.

  • Mechanism: NIV enhances oxygenation and ventilation using positive airway pressure, which prevents alveolar collapse and reduces the work of breathing.
  • Common Modes:
    • Continuous Positive Airway Pressure (CPAP): Maintains constant positive airway pressure throughout the respiratory cycle, improving oxygenation in conditions such as cardiogenic pulmonary edema.
    • Bilevel Positive Airway Pressure (BiPAP): Alternates between inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP), facilitating both oxygenation and ventilation, particularly in hypercapnic ARF seen in COPD exacerbations.
  • Clinical Application: NIV is widely used in exacerbations of chronic conditions like COPD, mild ARDS, and heart failure, where it can stabilize gas exchange and reduce the need for intubation.

Invasive Mechanical Ventilation (IMV)

In cases where non-invasive ventilation fails to stabilize ARF or is contraindicated, invasive mechanical ventilation provides controlled respiratory support through an endotracheal or tracheostomy tube.

  • Mechanism: IMV directly accesses the airway, ensuring precise delivery of oxygen, removal of carbon dioxide, and reduction of respiratory muscle workload. It also facilitates better protection against aspiration in patients with altered mental status or significant secretions.
  • Common Modes:
    • Assist-Control Ventilation (ACV): Delivers a preset tidal volume or pressure with every breath, whether initiated by the patient or the ventilator. ACV provides full respiratory support, ideal for patients with severe ARF and minimal respiratory effort.
    • Synchronized Intermittent Mandatory Ventilation (SIMV): Combines mandatory ventilator-delivered breaths with the patient’s spontaneous breaths. It is frequently used during weaning to encourage respiratory muscle activity.
    • Pressure Support Ventilation (PSV): Supports spontaneous breathing by delivering a set inspiratory pressure. It is commonly employed during recovery or as a step-down mode in the weaning process.
  • Clinical Application: IMV is indicated in severe ARF with refractory hypoxemia, hypercapnia unresponsive to NIV, or conditions like ARDS, where invasive strategies like lung-protective ventilation and high PEEP are essential.

Non-invasive ventilation often serves as the first-line treatment in ARF. However, in some cases, such as persistent hypoxemia, rising carbon dioxide levels, or respiratory distress that worsens despite NIV, transitioning to invasive mechanical ventilation becomes necessary to ensure adequate respiratory support and prevent further deterioration (9–11). The specific criteria and clinical scenarios guiding this transition will be examined in a subsequent section.

By tailoring the type of mechanical ventilation to the patient’s condition and response, clinicians can optimize outcomes while minimizing complications.

Modes of Mechanical Ventilation for ARF Treatment

The choice of mechanical ventilation mode in acute respiratory failure (ARF) is determined by the underlying pathology, severity of respiratory compromise, and patient-specific factors (11,12). Optimizing the mode of ventilation is essential to ensure adequate gas exchange while minimizing complications (12). Below, the most commonly used modes are outlined, with an emphasis on their applications and clinical significance.

Assist-Control Ventilation (ACV)

ACV provides full respiratory support by delivering a preset tidal volume (VT) or pressure with each breath, regardless of whether the breath is initiated by the patient or the ventilator.

  • Application: This mode is typically used in severe ARF, particularly in conditions such as ARDS or pneumonia, where patients may have minimal or absent spontaneous respiratory effort.
  • Advantages: Guarantees consistent ventilation and simplifies management in critically ill patients.

Synchronized Intermittent Mandatory Ventilation (SIMV)

SIMV delivers a set number of mandatory breaths, synchronized with the patient’s spontaneous respiratory efforts, allowing for unassisted breaths in between.

  • Application: Often employed as an intermediate step in patients transitioning from full ventilatory support to spontaneous breathing, such as during the weaning process.
  • Advantages: Promotes respiratory muscle activity while providing a safety net of mandatory ventilator breaths.

Pressure Support Ventilation (PSV)

PSV augments spontaneous breathing by providing a preset level of inspiratory pressure, reducing the effort required for inspiration.

  • Application: Commonly used in patients with preserved respiratory drive, such as those recovering from ARF or during non-invasive ventilation (NIV).
  • Advantages: Improves patient comfort, reduces work of breathing, and facilitates weaning from invasive ventilation.

Volume-Controlled and Pressure-Controlled Ventilation (VCV/PCV)

  • Volume-Controlled Ventilation (VCV) delivers a preset tidal volume, with airway pressure varying depending on lung compliance and resistance.

    Application: Used in patients requiring precise control of minute ventilation, such as those with hypercapnia.
  • Pressure-Controlled Ventilation (PCV) delivers a preset pressure during inspiration, with tidal volume varying based on lung compliance.

    Application: Beneficial in patients with reduced lung compliance, such as in ARDS, to limit peak airway pressures and reduce the risk of barotrauma.

High-Frequency Oscillatory Ventilation (HFOV)

HFOV delivers very small tidal volumes at high frequencies, maintaining continuous positive airway pressure.

  • Application: A rescue strategy for refractory hypoxemia in ARDS when conventional ventilation fails.
  • Advantages: Minimizes ventilator-induced lung injury (VILI) by preventing alveolar overdistension.

Clinical Significance

The selection of the appropriate mode of mechanical ventilation in ARF is crucial for optimizing outcomes and minimizing complications. For instance, lung-protective ventilation strategies, such as low tidal volume ventilation in ARDS, reduce the risk of ventilator-induced lung injury (11).
Modes like SIMV and PSV play key roles in facilitating weaning and restoring spontaneous respiratory function (11). By tailoring ventilation modes to the individual needs of patients, clinicians can address the specific pathophysiological challenges of ARF while improving survival and recovery rates (11-15).

Advanced Modes of Mechanical Ventilation: ASV, SAV, and NAVA

With the evolution of mechanical ventilation, advanced modes like Adaptive Support Ventilation (ASV), SmartCare/Automated Ventilation (SAV), and Neurally Adjusted Ventilatory Assist (NAVA) have emerged as pivotal tools in modern respiratory care. These modes leverage intelligent algorithms and neural control mechanisms to enhance patient outcomes, improve synchronization, and simplify clinical workflows. Below is a comprehensive discussion of each mode and its clinical significance (23-25).

Adaptive Support Ventilation (ASV)

  • What is ASV?
     ASV is an intelligent mode of mechanical ventilation that automatically adjusts ventilatory support based on the patient’s respiratory mechanics and effort. It uses algorithms to calculate the ideal tidal volume and respiratory rate based on the patient’s predicted body weight, lung compliance, and airway resistance (22-25).
  • How ASV Works:
    • ASV continuously monitors the patient’s spontaneous breathing.
    • It dynamically adjusts the inspiratory pressure and ventilatory rate to meet the patient’s metabolic demand while preventing over-distension or atelectasis.
    • This mode ensures minimal work of breathing while maintaining target minute ventilation.
  • Benefits of ASV:
    • Automatically reduces support as the patient’s respiratory effort improves, facilitating a smooth transition from controlled to spontaneous breathing.
    • Decreases the risk of hyperventilation, barotrauma, and ventilator-induced lung injury (VILI) (23,24).
    • Improves patient-ventilator synchrony, reducing discomfort and sedation requirements (24).
  • Evidence and Clinical Applications:
    • Studies have shown ASV to be effective in both acute and chronic respiratory failure. For example, research published in Critical Care (Arnal et al., 2008) demonstrated that ASV reduced ventilation duration compared to traditional modes in post-operative ICU patients (26).
    • It is widely used in settings requiring dynamic adaptation, such as weaning and managing variable lung mechanics in conditions like ARDS or COPD exacerbations (27).

SmartCare/Automated Ventilation (SAV)

  • What is SAV?
     SmartCare/Automated Ventilation is a closed-loop ventilation system designed primarily to automate the weaning process. It uses an artificial intelligence algorithm to assess and adjust ventilatory support based on real-time patient parameters (25,28-31).
  • How SAV Works:
    • SAV continuously monitors the patient’s respiratory rate, tidal volume, and end-tidal carbon dioxide (EtCO₂).
    • Based on these parameters, it adjusts pressure support levels to ensure adequate ventilation and oxygenation.
    • When the algorithm determines that the patient can sustain spontaneous breathing, it suggests readiness for extubation.
  • Benefits of SAV:
    • Speeds up the weaning process by reducing the need for manual adjustments (22-31).
    • Prevents premature or delayed extubation by following evidence-based criteria.
    • Reduces the workload for ICU staff and standardizes the weaning process.
  • Evidence and Clinical Applications:
    • Clinical trials, such as those published in Intensive Care Medicine (Lellouche et al., 2006), have shown that SmartCare reduces the duration of mechanical ventilation and ICU stay while improving extubation success rates (31).
    • SAV is especially useful in ICUs with high patient volumes or variability in care protocols (24-31).

Neurally Adjusted Ventilatory Assist (NAVA)

  • What is NAVA
    Neurally Adjusted Ventilatory Assist (NAVA) is an advanced mode of mechanical ventilation that directly uses the patient’s neural respiratory drive to control ventilatory support. Unlike traditional modes that rely on airway pressure or flow triggers, NAVA is driven by electrical activity in the diaphragm (Edi), offering highly personalized and precise ventilation (25-34).
  • How NAVA Works?

    Edi Catheter:
    A specialized nasogastric catheter detects electrical signals from the diaphragm during the patient’s spontaneous breathing efforts.

    Signal Processing:
    These signals (Edi) are analyzed in real-time to determine the timing, duration, and intensity of inspiratory effort.

    Ventilator Response:
    The ventilator delivers pressure support proportional to the patient’s effort, ensuring optimal synchronization and avoiding over-assistance or under-assistance.
  • Advantages of NAVA

    Improved Patient-Ventilator Synchrony:
    NAVA directly responds to the patient’s neural respiratory signals, eliminating delays and mismatches that occur with pressure or flow triggering.
    Reduces asynchrony-related complications, such as ineffective efforts, double triggering, and patient discomfort.

    Reduction in Sedation Needs:
    By providing natural, synchronized support, NAVA minimizes the discomfort associated with mechanical ventilation, reducing the need for sedatives.

    Enhanced Respiratory Muscle Protection:
    Unlike traditional modes that can over-assist, leading to respiratory muscle atrophy, NAVA ensures the diaphragm remains active, maintaining muscle strength and endurance.

    Personalized Ventilation:
    Adapts dynamically to the patient’s changing respiratory demands, particularly in conditions like ARDS, COPD, or neuromuscular disorders.
  • Clinical Applications of NAVA

    ARDS and Acute Respiratory Failure (ARF):
    NAVA provides lung-protective ventilation by avoiding overdistension and barotrauma while maintaining synchrony (38).

    Neonatal and Pediatric Ventilation:
    Especially useful in premature infants and pediatric patients, where synchrony challenges are common with traditional modes (36-37,39-43).

    Weaning:
    Facilitates a gradual reduction in ventilatory support by responding to the patient’s natural efforts (44-45).

    NAVA represents a significant advancement in mechanical ventilation, focusing on precision and patient-centric care by using the diaphragm’s electrical activity to guide support. Its ability to enhance patient-ventilator synchrony, reduce sedation needs, and protect respiratory muscles makes it an invaluable mode in both adult and pediatric populations. When combined with other modes like ASV and SAV, NAVA provides a versatile and comprehensive approach to managing acute respiratory failure.

When to Transition from Non-Invasive Mechanical Ventilation (NIMV) to Invasive Mechanical Ventilation (IMV) in ARF

Non-invasive mechanical ventilation (NIMV) is often the first-line treatment for acute respiratory failure (ARF) in specific conditions like COPD exacerbations or mild-to-moderate hypoxemia. However, in some cases, NIMV may fail to provide adequate support, requiring a transition to invasive mechanical ventilation (IMV) to prevent further deterioration. Here are the key indicators and clinical scenarios to consider transitioning:

1. Worsening Gas Exchange Despite NIMV

  • Signs:
    • Persistent or worsening hypoxemia (PaO₂ < 60 mmHg on FiO₂ ≥ 0.6).
    • Rising PaCO₂ (> 50 mmHg) with associated respiratory acidosis (pH < 7.25).
  • Reason: Indicates that NIMV is insufficient to meet oxygenation or ventilation demands.

2. Severe Respiratory Distress

  • Signs:
    • Increased respiratory rate (> 35 breaths/min).
    • Use of accessory muscles, paradoxical breathing, or nasal flaring.
    • Inability to speak in full sentences due to dyspnea.
  • Reason: Suggests that the patient’s work of breathing has exceeded the support provided by NIMV, risking respiratory muscle fatigue and collapse.

3. Altered Mental Status

  • Signs:
    • Confusion, agitation, or inability to cooperate with NIMV.
    • Progression to somnolence or coma (indicating hypercapnia or hypoxemia affecting cerebral function).
  • Reason: Neurological impairment reduces the ability to maintain spontaneous breathing or adhere to NIMV.

4. Hemodynamic Instability

  • Signs:
    • Hypotension (systolic blood pressure < 90 mmHg) unresponsive to fluid resuscitation.
    • Shock or signs of reduced cardiac output.
  • Reason: Indicates systemic compromise that requires better oxygenation and ventilation control via IMV.

5. Risk of Aspiration or Airway Protection Issues

  • Signs:
    • Inability to clear secretions or significant mucus plugging.
    • Frequent vomiting or risk of aspiration (e.g., altered consciousness).
  • Reason: IMV is necessary to secure the airway with an endotracheal tube to prevent aspiration-related complications.

6. Failure to Tolerate NIMV

  • Signs:
    • Poor mask seal due to facial anatomy or agitation.
    • Skin breakdown or discomfort causing discontinuation of therapy.
  • Reason: Intolerance to NIMV can reduce adherence, rendering it ineffective.

7. No Clinical Improvement Within 1–2 Hours of NIMV

  • Signs:
    • Lack of improvement in respiratory rate, gas exchange, or oxygenation after 1–2 hours of optimal NIMV.
  • Reason: Delaying the switch to IMV increases the risk of respiratory arrest and worsens outcomes.

The decision to switch from NIMV to IMV in ARF should be guided by clinical judgment, monitoring of gas exchange, respiratory mechanics, and overall patient stability. Early recognition of NIMV failure and timely intubation improve outcomes and prevent complications associated with delayed intervention (12-14, 16-21).

References

  1. Kapil S, Wilson JG. Mechanical Ventilation in Hypoxemic Respiratory Failure. Emerg Med Clin North Am. 2019;37(3):431-444. doi:10.1016/j.emc.2019.04.005
  2. Delerme S, Ray P. Acute respiratory failure in the elderly: diagnosis and prognosis. Age Ageing. 2008;37(3):251-257. doi:10.1093/ageing/afn060
  3. Antro C, Merico F, Urbino R, Gai V. Non-invasive ventilation as a first-line treatment for acute respiratory failure: “real life” experience in the emergency department. Emerg Med J. 2005;22(11):772-777. doi:10.1136/emj.2004.018309
  4. Piraino T. Noninvasive Respiratory Support in Acute Hypoxemic Respiratory Failure. Respir Care. 2019;64(6):638-646. doi:10.4187/respcare.06735
  5. Abellan C, Bertin C, Fumeaux T, Carrel L. Insuffisance respiratoire aiguë : prise en charge hospitalière non invasive [Acute respiratory failure : non-invasive hospital management]. Rev Med Suisse. 2020;16(705):1636-1644.
  6. Munshi L, Mancebo J, Brochard LJ. Noninvasive Respiratory Support for Adults with Acute Respiratory Failure. N Engl J Med. 2022;387(18):1688-1698. doi:10.1056/NEJMra2204556
  7. Pisani L, Corcione N, Nava S. Management of acute hypercapnic respiratory failure. Curr Opin Crit Care. 2016;22(1):45-52. doi:10.1097/MCC.0000000000000269
  8. Liu YJ, Zhao J, Tang H. Non-invasive ventilation in acute respiratory failure: a meta-analysis. Clin Med (Lond). 2016;16(6):514-523. doi:10.7861/clinmedicine.16-6-514
  9. Pham T, Brochard LJ, Slutsky AS. Mechanical Ventilation: State of the Art. Mayo Clin Proc. 2017;92(9):1382-1400. doi:10.1016/j.mayocp.2017.05.004
  10. Tobin MJ, Laghi F, Jubran A. Ventilatory failure, ventilator support, and ventilator weaning. Compr Physiol. 2012;2(4):2871-2921. doi:10.1002/cphy.c110030
  11. Tobin, M. J. (2013). Principles and practice of mechanical ventilation, 3e. McGraw-Hill Education LLC.
  12. Pinsky MR. Toward a better ventilation strategy for patients with acute lung injury. Crit Care. 2000;4(4):205-206. doi:10.1186/cc695
  13. Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017;50(2):1602426. Published 2017 Aug 31. doi:10.1183/13993003.02426-2016
  14. Torres A, Niederman MS, Chastre J, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT). Eur Respir J. 2017;50(3):1700582. Published 2017 Sep 10. doi:10.1183/13993003.00582-2017
  15. Oczkowski S, Ergan B, Bos L, et al. ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure. Eur Respir J. 2022;59(4):2101574. Published 2022 Apr 14. doi:10.1183/13993003.01574-2021
  16. Luo F, Annane D, Orlikowski D, et al. Invasive versus non-invasive ventilation for acute respiratory failure in neuromuscular disease and chest wall disorders. Cochrane Database Syst Rev. 2017;12(12):CD008380. Published 2017 Dec 4. doi:10.1002/14651858.CD008380.pub2
  17. Blumenthal JA, Duvall MG. Invasive and noninvasive ventilation strategies for acute respiratory failure in children with coronavirus disease 2019. Curr Opin Pediatr. 2021;33(3):311-318. doi:10.1097/MOP.0000000000001021
  18. Shang P, Zhu M, Baker M, Feng J, Zhou C, Zhang HL. Mechanical ventilation in Guillain-Barré syndrome. Expert Rev Clin Immunol. 2020;16(11):1053-1064. doi:10.1080/1744666X.2021.1840355
  19. Davidson AC, Banham S, Elliott M, et al. BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults [published correction appears in Thorax. 2017 Jun;72(6):588. doi: 10.1136/thoraxjnl-2015-208209corr1]. Thorax. 2016;71 Suppl 2:ii1-ii35. doi:10.1136/thoraxjnl-2015-208209      
  20. Kress JP, O’Connor MF, Schmidt GA. Clinical examination reliably detects intrinsic positive end-expiratory pressure in critically ill, mechanically ventilated patients. Am J Respir Crit Care Med. 1999;159(1):290-294. doi:10.1164/ajrccm.159.1.9805011
  21. Rittayamai N, Katsios CM, Beloncle F, Friedrich JO, Mancebo J, Brochard L. Pressure-Controlled vs Volume-Controlled Ventilation in Acute Respiratory Failure: A Physiology-Based Narrative and Systematic Review. Chest. 2015;148(2):340-355. doi:10.1378/chest.14-3169
  22. Brunner JX, Iotti GA. Adaptive Support Ventilation (ASV). Minerva Anestesiol. 2002;68(5):365-368.
  23. Dai YL, Hsu RJ, Huang HK, et al. Adaptive support ventilation attenuates postpneumonectomy acute lung injury in a porcine model. Interact Cardiovasc Thorac Surg. 2020;31(5):718-726. doi:10.1093/icvts/ivaa157
  24. Buiteman-Kruizinga LA, Mkadmi HE, Schultz MJ, Tangkau PL, van der Heiden PLJ. Comparison of Mechanical Power During Adaptive Support Ventilation Versus Nonautomated Pressure-Controlled Ventilation-A Pilot Study. Crit Care Explor. 2021;3(2):e0335. Published 2021 Feb 15. doi:10.1097/CCE.0000000000000335
  25. Fernández J, Miguelena D, Mulett H, Godoy J, Martinón-Torres F. Adaptive support ventilation: State of the art review. Indian J Crit Care Med. 2013;17(1):16-22. doi:10.4103/0972-5229.112149
  26. Arnal JM, Wysocki M, Nafati C, et al. Automatic selection of breathing pattern using adaptive support ventilation. Intensive Care Med. 2008;34(1):75-81. doi:10.1007/s00134-007-0847-0
  27. Zhu F, Gomersall CD, Ng SK, Underwood MJ, Lee A. A randomized controlled trial of adaptive support ventilation mode to wean patients after fast-track cardiac valvular surgery. Anesthesiology. 2015;122(4):832-840. doi:10.1097/ALN.0000000000000589
  28. Rose L, Schultz MJ, Cardwell CR, Jouvet P, McAuley DF, Blackwood B. Automated versus non-automated weaning for reducing the duration of mechanical ventilation for critically ill adults and children. Cochrane Database Syst Rev. 2014;2014(6):CD009235. Published 2014 Jun 10. doi:10.1002/14651858.CD009235.pub3
  29. Rose L, Schultz MJ, Cardwell CR, Jouvet P, McAuley DF, Blackwood B. Automated versus non-automated weaning for reducing the duration of mechanical ventilation for critically ill adults and children: a cochrane systematic review and meta-analysis. Crit Care. 2015;19(1):48. Published 2015 Feb 24. doi:10.1186/s13054-015-0755-6
  30. Wysocki M, Jouvet P, Jaber S. Closed loop mechanical ventilation. J Clin Monit Comput. 2014;28(1):49-56. doi:10.1007/s10877-013-9465-2
  31. Lellouche F, Mancebo J, Jolliet P, et al. A multicenter randomized trial of computer-driven protocolized weaning from mechanical ventilation. Am J Respir Crit Care Med. 2006;174(8):894-900. doi:10.1164/rccm.200511-1780OC
  32. Shah SD, Anjum F. Neurally Adjusted Ventilatory Assist (NAVA). In: StatPearls. Treasure Island (FL): StatPearls Publishing; May 22, 2023.
  33. Navalesi P, Longhini F. Neurally adjusted ventilatory assist. Curr Opin Crit Care. 2015;21(1):58-64. doi:10.1097/MCC.0000000000000167
  34. Sheng Y, Shao W, Wang Y, Kang X, Hu R. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023;35(11):1229-1232. doi:10.3760/cma.j.cn121430-20230222-00101
  35. Vahedi NB, Ramazan-Yousif L, Andersen TS, Jensen HI. Implementation of Neurally Adjusted Ventilatory Assist (NAVA): Patient characteristics and staff experiences. J Healthc Qual Res. 2020;35(4):253-260. doi:10.1016/j.jhqr.2020.03.008
  36. Mandyam S, Qureshi M, Katamreddy Y, et al. Neurally Adjusted Ventilatory Assist Versus Pressure Support Ventilation: A Comprehensive Review. J Intensive Care Med. 2024;39(12):1194-1203. doi:10.1177/08850666231212807
  37. Sugunan P, Hosheh O, Garcia Cusco M, Mildner R. Neurally-Adjusted Ventilatory Assist (NAVA) versus Pneumatically Synchronized Ventilation Modes in Children Admitted to PICU. J Clin Med. 2021;10(15):3393. Published 2021 Jul 30. doi:10.3390/jcm10153393
  38. Umbrello M, Antonucci E, Muttini S. Neurally Adjusted Ventilatory Assist in Acute Respiratory Failure-A Narrative Review. J Clin Med. 2022;11(7):1863. Published 2022 Mar 28. doi:10.3390/jcm11071863
  39. Beck J, Emeriaud G, Liu Y, Sinderby C. Neurally-adjusted ventilatory assist (NAVA) in children: a systematic review. Minerva Anestesiol. 2016;82(8):874-883.
  40. Minamitani Y, Miyahara N, Saito K, Kanai M, Namba F, Ota E. Noninvasive neurally-adjusted ventilatory assist in preterm infants: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2024;37(1):2415373. doi:10.1080/14767058.2024.2415373
  41.  Fang SJ, Su CH, Liao DL, et al. Neurally adjusted ventilatory assist for rapid weaning in preterm infants. Pediatr Int. 2023;65(1):e15360. doi:10.1111/ped.15360
  42. Rossor TE, Hunt KA, Shetty S, Greenough A. Neurally adjusted ventilatory assist compared to other forms of triggered ventilation for neonatal respiratory support. Cochrane Database Syst Rev. 2017;10(10):CD012251. Published 2017 Oct 27. doi:10.1002/14651858.CD012251.pub2
  43. Stein H, Beck J, Dunn M. Non-invasive ventilation with neurally adjusted ventilatory assist in newborns. Semin Fetal Neonatal Med. 2016;21(3):154-161. doi:10.1016/j.siny.2016.01.006
  44. Liu L, Xu X, Sun Q, et al. Neurally Adjusted Ventilatory Assist versus Pressure Support Ventilation in Difficult Weaning: A Randomized Trial. Anesthesiology. 2020;132(6):1482-1493. doi:10.1097/ALN.0000000000003207
  45. Yuan X, Lu X, Chao Y, et al. Neurally adjusted ventilatory assist as a weaning mode for adults with invasive mechanical ventilation: a systematic review and meta-analysis. Crit Care. 2021;25(1):222. Published 2021 Jun 29. doi:10.1186/s13054-021-03644-z

Blog_Cover1

Acute Respiratory Failure: Causes and Mechanisms

by ICU Ventilator

Acute respiratory failure (ARF) is a critical condition characterized by the respiratory system’s inability to maintain adequate gas exchange, presenting an immediate threat to life. Its etiologies encompass a wide range of conditions, including acute respiratory distress syndrome (ARDS), pneumonia, exacerbations of chronic obstructive pulmonary disease (COPD), and neuromuscular disorders, all necessitating timely and effective intervention.

Acute respiratory failure (ARF) is a life-threatening condition defined by the respiratory system’s inability to maintain adequate gas exchange, resulting in critically low oxygen levels in the blood (hypoxemia), elevated carbon dioxide levels (hypercapnia), or a combination of both (1). ARF can result from diverse etiologies, including acute respiratory distress syndrome (ARDS), pneumonia, chronic obstructive pulmonary disease (COPD) exacerbations, pulmonary embolism, neuromuscular disorders, or trauma (2, 3). These conditions impair the lung’s capacity to oxygenate blood and eliminate carbon dioxide, leading to severe systemic consequences if not managed promptly and effectively.

What is Acute Respiratory Failure?

Acute respiratory failure (ARF) is a medical condition in which the respiratory system fails to perform its primary function of effective gas exchange. This failure leads to inadequate oxygenation of the blood (hypoxemia), impaired elimination of carbon dioxide from the body (hypercapnia), or both (1). ARF can develop rapidly as a result of various underlying pathologies affecting the lungs, airways, chest wall, or central nervous system (2, 3).

ARF is often a life-threatening emergency that necessitates immediate medical intervention to prevent severe complications or death.

Basic Physiology of the Respiratory System

The primary role of the respiratory system is to facilitate gas exchange, ensuring oxygen delivery to tissues and carbon dioxide removal. This process depends on the proper functioning of several components (5–7):

  1. Ventilation: The physical movement of air into and out of the lungs, determined by respiratory muscle effort and airway patency.
  2. Diffusion: The exchange of gases between the alveoli and pulmonary capillaries, driven by partial pressure gradients.
  3. Perfusion: The blood flow through pulmonary capillaries, enabling gas exchange.

In ARF, a disruption in one or more of these components impairs gas exchange:

  • Hypoxemic ARF: Defined as PaO₂ < 60 mmHg with normal or low PaCO₂, resulting from impaired oxygenation.
  • Hypercapnic ARF: Defined as PaCO₂ > 45 mmHg with acidemia, caused by inadequate ventilation.

Pathophysiological Mechanisms of ARF

MechanismDefinitionCausesEffect
Ventilation-Perfusion (V/Q) MismatchMismatch between ventilated and perfused lung areas.Pulmonary embolism, pneumonia, atelectasis.Hypoxemia.
Diffusion ImpairmentReduced oxygen transfer across the alveolar-capillary membrane.ARDS, pulmonary fibrosis, interstitial pneumonia.Hypoxemia despite adequate ventilation.
HypoventilationReduced air movement in and out of the lungs, leading to CO₂ retention.CNS depression, neuromuscular disorders, obesity.Hypercapnia and secondary hypoxemia.
ShuntingBlood bypasses ventilated alveoli, preventing oxygenation.ARDS, pneumonia, large atelectasis.Severe hypoxemia unresponsive to oxygen therapy.
Increased Work of BreathingRespiratory muscles overwork to overcome resistance or poor compliance.COPD exacerbations, asthma, ARDS.Respiratory fatigue and eventual failure.
Table 1: Pathophysiological Mechanisms of ARF

Ventilation-Perfusion (V/Q) Mismatch

  • Definition: A mismatch occurs when areas of the lungs are ventilated but not perfused, or perfused but not ventilated.
  • Causes: Pulmonary embolism (low perfusion), pneumonia, or atelectasis (low ventilation).
  • Effect: Impairs oxygen delivery and carbon dioxide removal, causing hypoxemia.

Diffusion Impairment

  • Definition: Thickening or damage to the alveolar-capillary membrane reduces oxygen transfer to the blood.
  • Causes: Pulmonary fibrosis, ARDS, or severe interstitial pneumonia.
  • Effect: Decreases arterial oxygenation despite adequate ventilation.

Hypoventilation

  • Definition: Reduced air movement in and out of the lungs leads to insufficient CO₂ elimination.
  • Causes: Central nervous system depression (e.g., drug overdose), neuromuscular disorders (e.g., Guillain-Barré syndrome), or severe obesity.
  • Effect: Causes hypercapnia and secondary hypoxemia.

Shunting

  • Definition: Blood flows through areas of the lungs without gas exchange, bypassing functional alveoli.
  • Causes: ARDS, pneumonia, or large atelectasis.
  • Effect: Results in severe hypoxemia unresponsive to oxygen therapy.

Increased Work of Breathing

  • Definition: Respiratory muscles work harder to overcome airway resistance or reduced lung compliance.
  • Causes: COPD exacerbations, asthma, or ARDS.
  • Effect: Leads to respiratory muscle fatigue and eventual failure.

What are the Main Causes of Acute Respiratory Failure?

CategoryCausesExamples
Pulmonary CausesConditions directly impairing lung function.ARDS, pneumonia, COPD exacerbations, asthma, pulmonary embolism.
Extrapulmonary CausesConditions indirectly affecting the respiratory system.Neuromuscular disorders, CNS depression, thoracic cage abnormalities.
Trauma and External FactorsPhysical trauma or external agents affecting ventilation.Chest trauma, sedative overdose, toxins, or neuromuscular blockers.
Table 2: Main Causes of ARF

Acute respiratory failure (ARF) arises from a wide range of conditions affecting the respiratory system or its control mechanisms. These causes are broadly categorized as pulmonary causes, such as ARDS and pneumonia, directly impair lung function, while extrapulmonary causes, including neuromuscular disorders and CNS depression, indirectly disrupt respiratory mechanics:

Pulmonary Causes

  • Acute Respiratory Distress Syndrome (ARDS): Severe lung inflammation and alveolar damage leading to profound hypoxemia.
  • Pneumonia: Infectious consolidation of lung tissue impairs ventilation and gas exchange.
  • Chronic Obstructive Pulmonary Disease (COPD) Exacerbations: Increased airway obstruction and gas trapping result in hypercapnia.
  • Asthma: Severe bronchoconstriction impairs airflow, causing hypoxemia and hypercapnia.
  • Pulmonary Embolism (PE): Blockage of pulmonary arteries disrupts perfusion.

Extrapulmonary Causes

  • Neuromuscular Disorders: Conditions like Guillain-Barré syndrome or myasthenia gravis weaken respiratory muscles, reducing ventilation.
  • Central Nervous System Depression: Stroke, trauma, or sedative overdose impairs respiratory drive.
  • Thoracic Cage Abnormalities: Structural conditions such as kyphoscoliosis limit lung expansion.
  • Obesity Hypoventilation Syndrome: Excess weight restricts chest wall movement, leading to hypoventilation.

Trauma and External Factors

  • Chest Trauma: Rib fractures or pneumothorax compromise ventilation mechanics.
  • Toxins and Medications: Sedatives, opioids, or neuromuscular blockers depress respiratory effort or muscle function.

ARF is a multifaceted condition with diverse etiologies that disrupt normal respiratory physiology (3). Hypoxemia and hypercapnia serve as key markers of dysfunction, emphasizing the importance of understanding the underlying pathology for timely and effective management. Accurate diagnosis and targeted interventions, including mechanical ventilation, are essential to restoring respiratory function and preventing severe complications.

References

  1. Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017;50(2):1602426. Published 2017 Aug 31. doi:10.1183/13993003.02426-2016
  2. Chen L, Rackley CR. Diagnosis and Epidemiology of Acute Respiratory Failure. Crit Care Clin. 2024;40(2):221-233. doi:10.1016/j.ccc.2023.12.001
  3. Bos LDJ, Ware LB. Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes. Lancet. 2022;400(10358):1145-1156. doi:10.1016/S0140-6736(22)01485-4
  4. Villgran VD, Lyons C, Nasrullah A, Clarisse Abalos C, Bihler E, Alhajhusain A. Acute Respiratory Failure. Crit Care Nurs Q. 2022;45(3):233-247. doi:10.1097/CNQ.0000000000000408
  5. Haddad M, Sharma S. Physiology, Lung. In: StatPearls. Treasure Island (FL): StatPearls Publishing; July 20, 2023.
  6. Roussos C, Koutsoukou A. Respiratory failure. Eur Respir J Suppl. 2003;47:3s-14s. doi:10.1183/09031936.03.000385037.     Ware LB. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin Respir Crit Care Med. 2006;27(4):337-349. doi:10.1055/s-2006-948288
  7. Ware LB. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin Respir Crit Care Med. 2006;27(4):337-349. doi:10.1055/s-2006-948288
Modes of Mechanical Ventilation | mechanical ventilation modes

The Most Common Modes of Mechanical Ventilation

by with No Comment Uncategorized

Mechanical ventilation is the process of using an external device (machine) to aid gaseous movement in and out of the lung. It serves as a type of life-saving device that facilitates breathing. Also, it’s widely used as an artificial breathing support in surgical cases, extremely ill situations, or when an individual is incapable of breathing on their own.  Various modes of mechanical ventilation play a great role in respiratory support, patient stabilization, and provision of pressure to prevent the alveoli from collapsing. Continue reading, as this article provides you with diverse mechanical ventilation modes and some of the most common modes of air circulation.

Modes of Mechanical Ventilation

Pressure Controlled Ventilation (PCV)

Pressure-controlled ventilation is a special kind of assisted respiration whereby a patient’s inspiratory pressure is predetermined. This mechanical ventilation mode provides an amount of aeration that depends on the compliance of the lungs and the resistance of the alveoli. It is an airflow system where the maximum airway force is constant and the total ventilation fluctuates. 

PCV is one of the most convincing pressure-limited ventilation (PLV) that is used regularly in the initial stages of newborn care. It is a technique recommended by different centers for preventing lobar emphysema. Although PCV reduces the risk of barotrauma, it could be challenging to provide a sufficient tidal volume (VT) when used in patients with ARDS. Also, an improper setting of this ventilator can lead to hypoxia and respiratory depression. 

Modes of Mechanical Ventilation

Volume Controlled Ventilation (VCV)

The modes of mechanical ventilation that involves a preset tidal volume to be provided in a specific amount of time is volume-controlled ventilation. It is usually more simple and comprehensible for most medical practitioners new to assisted air circulation. In this case, total ventilation is always set, the volume of breath supplied is constant, but the inspiratory pressure is unstable. 

Most of the time, VCV is commonly used in anesthesia, either in the assisted control (AC) mode or continuous mandatory ventilation (CMV). Due to the increase in peak pressure (PIP) with steady and accurate breathing volume, it usually causes uneven gaseous distribution and volutrauma. 

Pressure Support Ventilation (PSV)

A special mode of positive-pressure mechanical ventilation that requires patient initiation of each breath is known as pressure support ventilation. This kind of aided respiration can be administered either through the use of intubation (invasive) or with a mask (non-invasive) ventilatory pattern. It’s known as the most pleasant aided airflow with a useful system that delivers the benefits of the two types of ventilator patterns. 

PSV involves setting maximum driving pressure which usually indicates the ventilator flow rate. Sometimes, the patient’s pulmonary compliance, airway resistance, PIP, and breathing efforts frequently affect this flow rate. There is no minimum minute ventilation and the tidal volume provided is influenced by the flow and rate of breathing. Due to a volatile VT, it may also make the lung distend excessively. 

Pressure-Limited Time-Cycled Ventilation

Another type of PLV (similar to a pressure-controlled ventilator) that was previously used in neonates is the time-cycled PLV. This mechanical ventilation mode makes use of a predetermined peak pressure and a specified volume of gas within an extended period. While breathing in, this triggered ventilator provides a steady flow of air to the patient. 

Previous reports about the use of pressure-limited time-cycled ventilation have shown that lungs are usually susceptible to atelectrauma and barotrauma conditions. In addition, it has been observed that one of the primary factors influencing ventilator-associated lung injury (VALI) is Total ventilation (VT).

mechanical ventilation modes

Synchronized Intermittent Mandatory Ventilation (SIMV)

This is a unique mode of mechanical ventilation that provides a fixed tidal volume at a predefined frequency. In most cases, synchronized intermittent mandatory air circulation always permits patients to voluntarily breathe on their own. SIMV produces a mandatory breath that is delivered at the same moment the patient starts initiating their breath (spontaneous breath). In addition, positive end-expository pressure (PEEP) can also be administered using this synchronized IMV method. 

SIMV is mostly required by people with COPD, neuromuscular disorder, or ARDS and is used alongside pressure support ventilation. In some instances where SIMV is improperly used, there may be an inability to initiate spontaneous breath, fluctuations in intrathoracic force, or severe respiratory failure. This technique of ventilation is risky for hyperventilation, consumes much time, and can cause infection, barotrauma, or cardiac arrhythmias.

Modes of Mechanical Ventilation

High Flow Nasal Cannula (HFNC)

A high-flow nasal cannula is an oxygen therapy commonly called a heated, humidified, high-flow nasal cannula (HHFNC). It entails the delivery of a flexible blend of warmed, humid, and oxygen-rich air at a variable pace that surpasses spontaneous pulmonary flow. Whenever this aeration is used to provide oxygen, the flow is significantly greater than that with conventional nasal cannulas. 

In addition, HFNC enhances the functional residual capacity, and accurate distribution of oxygen. This mechanical ventilation mode often has an outcome of improved breathing efficiency due to continuous high oxygen flow that often washes out the anatomical dead space. 

Self Adjustable Ventilation (SAV)

Self Adjustable Ventilation is a special ventilator that makes use of detectors to constantly alter the airflow in response to changes in air properties. With the help of this technique, indoor comfort, improved air exchange systems, and environmental sustainability are guaranteed. This often allows great flexibility in ventilator parameters and also blends soothingly with a wide range of conditions.

References

1.https://my.clevelandclinic.org/health/treatments/15368-mechanical-ventilation

2.https://www.sciencedirect.com/topics/medicine-and-dentistry/pressure-controlled-ventilation

3. https://ecampusontario.pressbooks.pub/mechanicalventilators/chapter/volume-control-ventilation/

4.https://ecampusontario.pressbooks.pub/mechanicalventilators/chapter/volume-control-ventilation/

5.https://pubmed.ncbi.nlm.nih.gov/31536312/#:~:text=

6.https://journals.lww.com/jcma/fulltext/2019/10000/volume_targeted_versus_pressure_limited.14.aspx#:~:text=

7. https://www.icliniq.com/articles/respiratory-health/synchronized-intermittent-mandatory-ventilation

8.https://www.uptodate.com/contents/high-flow-nasal-cannula-oxygen-therapy-in-children

mechanical-ventilation-and-ICU-ventilators

Mechanical Ventilation and ICU Ventilators: Learn All Details

by with No Comment Uncategorized

Mechanical ventilation and ICU ventilators are critical components in the management of patients with severe respiratory conditions. Understanding their functionality and application is essential for effective patient care. These technologies play an important role in supporting and stabilizing patients in critical conditions.

What is Ventilation? 

ICU Ventilation is the process of movement of air from the atmosphere through the airways to the terminal respiratory gas exchange units by the effort of the respiratory muscles or mechanical ICU ventilators if the patient is being ventilated. 

What is Respiration? 

Oxygen is essential for life. It is required by each human cell for its survival. It is abundantly present in the atmosphere and maintains a remarkably constant concentration of 20.9% in ambient air. Oxygen is taken up by the lungs through the act of inspiration and transported to the cells via the blood.

At the cellular level, oxygen is utilized for the production of energy. In this process, carbon dioxide is released and transported back via the blood to the lungs from where it is expired out into the atmosphere. The act of the exchange of oxygen and carbon dioxide is called respiration. 

What is the Difference Between ICU Ventilators and Respirator? 

A ventilator is a machine, a system using mechanical power and having several parts, each with a definite function and together performing a particular task. The task here is to provide all or part of the body’s work that is called breathing or ventilation. Respirator is an apparatus that people worn it over their mouth and nose or the entire face to prevent the inhalation of dangerous substances such as: dust, smoke, etc

Indications for Ventilation

Patients who require ventilatory support often develop a common pattern of physiological deterioration, including:

  • changes in respiratory rate
  • asynchronous respiratory pattern
  • changes in mental status and changes in level of consciousness
  • frequent oxygen desaturation despite increasing oxygen concentration
  • hypercapnia and respiratory acidosis
  • circulatory problems, including tachypnea, tachycardia, hypertension, or hypotension.(3)

What is Non-invasive Ventilation (NIV)?

NIV refers to the provision of respiratory support without direct tracheal intubation. As such, it aims to avoid some of the complications inherent with invasive ventilation, such as the need for sedation with risks of hemodynamic instability and subsequent risk of delirium, nosocomial infection, etc.(2)

Recommendations for the use of non-invasive ventilation(4):

  • COPD exacerbations
  • Facilitation of weaning/extubation in patients with COPD
  • Cardiogenic pulmonary edema
  • Immunosuppressed patients
  • Do-not-intubate status
  • End-stage patients as palliative measure
  • Extubation failure (COPD or congestive heart failure) (prevention)
  • Community-acquired pneumonia in COPD
  • Postoperative respiratory failure (prevention and treatment)
  • Prevention of acute respiratory failure in asthma

Goals of Mechanical Ventilation

One of the most important treads of life support in the emergency department is Mechanical ventilation (MV). It provides time for recovery until the patient’s physiological balance is restored. This is why MV alone is not a unique and specific treatment for a particular disease; however, it has two general and main purposes: to support the injured lung and to protect the healthy lung.

Specific Goals of Mechanical Ventilation

  • Reversal of Apnea
  • Reversal of Respiratory Distress
  • Reversal of Severe Hypoxemia
  • Reversal of Severe Hypercapnia
  • Goals of Mechanical Ventilation in Postoperative
  • Respiratory Failure and Trauma
  • Goals of Mechanical Ventilation in Shock

One of the specific goals of MV is to promote the optimization of arterial blood gas levels and acid-base balance by providing oxygen and eliminating carbon dioxide (ventilation).(1) For patients with chronic diseases MV can reduce the work of breathing by taking effort from respiratory muscles and maintaining long-term respiratory support.
The ventilator is not a magical therapy that makes patients better but simply a supportive therapy used until more definitive therapies have time to work.

Apnea

Patients with apnea, such as those who have suffered catastrophic central nervous system (CNS) damage, need the immediate institution of mechanical ventilation.(2)

Indications and Contraindications for Non-invasive Ventilation

Recognizing when and when not to use NIV is crucial for its effective application. Below, we have explained the indications and contraindications for non-invasive ventilation for you

Indications (3)

  • Moderate to severe dyspnoea
  • Tachypnoea (>25–30 breaths/minute)
  • Signs of increased work of breathing (abdominal paradox; accessory muscle use)
  • Fatigue
  • Acute-on-chronic respiratory failure: pH <7.35; pCO2 >6
  • Hypoxaemia (use with caution): paO2/FiO2 <27 Kpa

Contraindications (3)

  • Facial burns/trauma/recent facial upper airway surgery
  • Vomiting
  • Upper gastrointestinal surgery
  • Copious respiratory secretions
  • Severe hypoxemia
  • Hemodynamically instability
  • Severe co-morbidities
  • Confusion/agitation
  • Low Glasgow coma score
  • Unable to protect the airway
  • Bowel obstruction
  • Respiratory arrest

NIV today consists almost exclusively of the delivery of positive pressure ventilation via an external interface. There are six broad types of interfaces available;

  • total face masks (enclose mouth, nose, eyes)
  • full-face masks (enclose mouth and nose)
  • nasal mask (covers nose but not mouth)
  • mouthpieces (placed between lips and held in place by lip seal)
  • nasal pillows or plugs (inserted into nostrils)
  • helmet (covers the whole head/all or part of the neck – no contact with face).(3)

What is Invasive Ventilation?

Invasive mechanical ventilation requires access to the trachea, most commonly via an endotracheal tube, and represents the commonest reason for admission to the ICU.(5)ICU Ventilators.

Large multinational surveys confirm the common indications for invasive ventilation to be:

  • coma 16%
  • COPD 13%
  • ARDS 11%
  • heart failure 11%
  • pneumonia 11%
  • sepsis 11%
  • trauma 11%
  • postoperative complications 11%
  • neuromuscular disorders 5%.
  • NIV contraindications.(5)

Let’s Meet with Biyovent ICU Type Mechanical Ventilator

ICU Ventilators

Biyovent ICU Type Mechanical Ventilator

ICU Ventilator of Biyovent makes a difference in the ventilation process with its unique specifications. Biyovent has been carefully thought out with every detail of the ventilators and developed with a holistic approach. Prepared for mass production in cooperation with Arçelik, Baykar, and Aselsan. ICU Ventilators

What are some specific features of Biyovent?

⦁ Invasive and Non-invasive Ventilation
⦁ Integrated Nebulizer
⦁ High Flow Oxygen Therapy
⦁ Suitable for Pediatric, Adult and Newborn (Optional) Patients
⦁ Smart Ventilation Modes

Learn more details about Biyovent ICU Ventilator

Get in contact with the Biosys Sales Team

References


1- Frank Lodeserto MD, “Simplifying Mechanical Ventilation – Part I: Types of Breaths”, REBEL EM blog, March 8, 2018. Available at: https://rebelem.com/simplifying-mechanical-ventilation-part/.
2- Tobin M.J. 3rd edn. McGraw-Hill Education; 2012. Principles and practice of mechanical ventilation.
3- Popat B, Jones AT. Invasive and non-invasive mechanical ventilation. Medicine (Abingdon). 2012;40(6):298-304. doi:10.1016/j.mpmed.2012.03.010
4- Hess D.R. The evidence for noninvasive positive-pressure ventilation in the care of patients in acute respiratory failure: a systematic review of the literature. Respir Care. 2004;49:810–829.
5- Esteban A., Ferguson N.D., Meade M.O. Evolution of mechanical ventilation in response to clinical research. Am J Respir Crit Care Med. 2008;177:170–177